Results 121 to 130 of about 13,466 (213)

Sclerostin Alters Tumor Cell Characteristics of Oral Squamous Cell Carcinoma and May Be a Key Player in Local Bone Invasion

Cells
Localized jawbone invasion is a milestone in the progression of oral squamous cell carcinoma (OSCC). The factors that promote this process are not well understood. Sclerostin is known to be involved in bone metabolism and there are preliminary reports of
Uwe Schirmer, Sina Allegra Schneider, Tatjana Khromov, Felix Bremmer, Boris Schminke, Henning Schliephake, Klaus Liefeith, Phillipp Brockmeyer   +7 more
doaj   +1 more source

Association of serum sclerostin level with coronary artery calcification in maintenance hemodialysis patients

Linchuang shenzangbing zazhi, 2019
Objective To study the association of serum sclerostin level with coronary artery calcification in maintenance hemodialysis(MHD) patients. Methods The clinical data of 138 patients receiving MHD during January 2016 to January 2017 in Hemodialysis Center ...
CHENG Jin, WANG Wei, LIU Guo-xiang
doaj  

Sclerostin [PDF]

, 2020
openaire   +1 more source

Sclerostin as a new target of diabetes-induced osteoporosis

Frontiers in Endocrinology
Sclerostin, a protein synthesized by bone cells, is a product of the SOST gene. Sclerostin is a potent soluble inhibitor of the WNT signaling pathway, and is known to inhibit bone formation by inhibiting osteocyte differentiation and function. Currently,
Yanhua Li, Yaheng Luo, Debin Huang, Lele Peng   +3 more
doaj   +1 more source

Osteoglycin and Sclerostin Imbalance in Hypophosphatasia: Bone-Derived Markers of Mineralization and Systemic Involvement. [PDF]

Int J Mol Sci
Martínez-Heredia L, Toro-Comino C, Muñoz-Domene MJ, González-Cejudo T, Andreo-López MC, Contreras-Bolívar V, García-Fontana C, García-Fontana B, Muñoz-Torres M.   +8 more
europepmc   +1 more source

Elevated sclerostin levels in cerebrospinal fluid are associated with cognitive impairment in the Alzheimer's disease continuum. [PDF]

Alzheimers Dement (Amst)
Pignataro P, Dicarlo M, Urso D, Zecca C, Colaianni G, Dell'Abate MT, Vilella D, Borlizzi F, Suriano C, Oranger A, Colucci S, Grano M, Logroscino G.   +12 more
europepmc   +1 more source

Mechanisms underlying the waning of osteoanabolic therapy effects in osteoporosis. [PDF]

J Bone Miner Res
Ferrari S, Thouverey C, Gerbaix M.
europepmc   +1 more source

Stage-Dependent Peri-Implant Bone Remodelling Under Occlusal Contact in a Murine Model. [PDF]

Int Dent J
Cao R, Takemura Y, Moriyama Y, Lai W, Chen X, Izumi A, Abe M, Ayukawa Y.   +7 more
europepmc   +1 more source

Bispecific antibody against sclerostin and DKK1 improves bone health and reduces bone marrow adipose tissue accumulation in experimental chronic kidney disease. [PDF]

Bone Res
Promruk W, Jayash SN, Chutoe C, Ke HZ, Liu X, Wade RL, von Kriegsheim A, Cawthorn WP, Staines KA, Stephen LA, Farquharson C.   +10 more
europepmc   +1 more source

Irisin treatment counteracts bone loss and muscle atrophy in aged mice by reducing sclerostin expression in bone and skeletal muscle. [PDF]

J Transl Med
Suriano C, Zerlotin R, Taurino M, Dicarlo M, Storlino G, Pignataro P, Terrevoli OD, Pellicani L, Oranger A, Mori G, Passeri G, Colucci SC, Colaianni G, Grano M.   +13 more
europepmc   +1 more source